Kanchan Kohli

Employment

• Jamia Hamdard Professor and Head, Department of Pharmaceutics
  2017 - Present
• Jamia Hamdard Professor/Dr.
  2005 - Present
• jamia hamdard Associate Professor/Dr.
  2000 - 2005
• Jamia Hamdard Assistant Professor/Dr.
  1990 - 2000
• Jamia Hamdard Faculty of Pharmacy Senior Lecturer
  1989 - 1990
• Jamia Hamdard Faculty of Pharmacy Lecturer
  1988 - 1989

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (34)

• Sirolimus loaded polyol modified liposomes for the treatment of Posterior Segment Eye Diseases
  Medical Hypotheses 2020 DOI: 10.1016/j.mehy.2019.109518
  +Save
• Optimisation of ethosomal nanogel for topical nano-CUR and sulphoraphane delivery in effective skin cancer therapy
  Journal of Microencapsulation 2019 DOI: 10.1080/02652048.2019.1701114
  +Save
• Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products
  Drug Discovery Today 2019 DOI: 10.1016/j.drudis.2018.12.002
  +Save
• Sulforaphane-decorated gold nanoparticle for anti-cancer activity: in vitro and in vivo studies
  Pharmaceutical Development and Technology 2019 DOI: 10.1080/10837450.2018.1507038
  +Save
• Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies
  Journal of Pharmaceutical Sciences 2019 DOI: 10.1016/j.xphs.2019.06.003
  +Save
• Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approach
  Medical Hypotheses 2019 DOI: 10.1016/j.mehy.2019.109379
  +Save
• Application of salt engineering to reduce/mask bitter taste of clindamycin
  Drug Development and Industrial Pharmacy 2019 DOI: 10.1080/03639045.2019.1672715
  +Save
• Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments
  Artificial Cells, Nanomedicine, and Biotechnology 2018 DOI: 10.1080/21691401.2017.1408124
  +Save
• Risk Assessment Integrated QbD Approach for Development of Optimized Bicontinuous Mucoadhesive Limicubes for Oral Delivery of Rosuvastatin
  AAPS PharmSciTech 2018 DOI: 10.1208/s12249-018-0951-1
  +Save
• Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model.
  Pharmaceutical biology 2017 DOI: 10.1080/13880209.2017.1299768
  +Save